MAEA Automates AI Development for medical applications cutting R&D cycles from months to days.

By ModAstera
26 May 2025
If you’ve ever tried to build a clinically-robust AI model, you know the pain points: endless data wrangling, GPU bills that blow the budget, and weeks of compliance paperwork just to reach a prototype. The traditional pipeline is slow, costly, and brutally complex – and in healthcare, delays and overruns don’t just hurt margins; they delay better patient outcomes.
From raw data to production-grade model in minutes, not months – no code, no DevOps, and no seven-figure consulting bill. The impact is already tangible. Researchers at Tohoku University Hospital cut their development timeline by 90 % while creating a brain-age prediction model that previously took an entire quarter to prototype. That’s time they can now devote to new hypotheses, publications, and ultimately, better care.
Today, we’re opening a limited Closed Beta for visionary health-tech teams who want to:
Reserve a demo slot here https://calendly.com/modastera/maea-demo – seats are filling quickly.
Let’s build medical innovation at the speed of thought. Welcome to the future of AI in healthcare.
ModAstera and Wellgen Medical are partnering to build AI screening models for cancer cytology, combining FDA-cleared tomographic imaging, clinical datasets, and rapid medical AI deployment.
ModAstera welcomes Prof. Christian Aldridge, a leading UK dermatologist and skin cancer authority, as Chief Medical Officer to drive clinical governance across Hebra and MAEA.
ModAstera participated in the Qualcomm AI Program for Innovators (QAIPI) 2025 APAC Demo Day in Seoul, showcasing our vision for secure, privacy-preserving medical AI and deepening collaboration within the global AI ecosystem.